The FDAs Stance and Why It Misses the Mark In 2023, the FDA classified BPC-157 as a Category 2 bulk drug substance , meaning it raises significant safety concerns. The agency specifically cited risks of immunogenicity , peptide-related impurities , and lack of sufficient safety data for human use
The microbial metabolism of BAs begins in deconjugation, removing the taurine or glycine from BAs, this process is conducted by bile salt hydrolase-producing bacteria
Low B12 in the body is also associated with having poor energy, frequent fatigue, and weakness
HGH is a classic systemic hormone affecting the entire body
Both doctors believe social media promoting unrealistic body aesthetics, hype from influencers such as Gary Brecka and Joe Rogan, and frustration with the slow pace of conventional injury recovery are factors behind interest in products
1 2 "Drug Fact Sheet: Narcotics" (PDF)